US RE046,284 E1
Method of administrating an anticancer drug containing α, α, α-trifluorothymidine and thymidine phosphorylase inhibitorGeneral
US RE046,284 E1
Method of administrating an anticancer drug containing α, α, α-trifluorothymidine and thymidine phosphorylase inhibitor
Tech Center:
3900 Reexam/Abandonments
Examiner:
Johnny F Railey
Art Unit:
3991 Central Reexamination Unit
Inventors:
Tomohiro EMURA; Akira MITA
Assignee:
Priority:
01/26/05
Filed:
12/30/15
Granted:
01/24/17
Expiration:
12/30/35
Abstract
The present invention relates to a method for treating a cancer comprising orally administering a composition containing α,α,α-trifluorothymidine (FTD) and 5-chloro-6-(1-(2-iminopyrrolidinyl)methyl)uracil hydrochloride in a molar ratio of 1:0.5 at a dose of 20 to 80 mg/m2/day in terms of FTD in 2 to 4 divided portions per to patients in need of the treatment.